Hydergin-Fas may be available in the countries listed below.
Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Hydergin-Fas in the following countries:
International Drug Name Search
Hysco may be available in the countries listed below.
Scopolamine hydrobromide (a derivative of Scopolamine) is reported as an ingredient of Hysco in the following countries:
International Drug Name Search
Relieving congestion, cough, and throat and airway irritation due to colds, flu, or hay fever. It may also be used for other conditions as determined by your doctor.
Dextromethorphan/Guaifenesin/Pseudoephedrine Drops are a decongestant, cough suppressant, and expectorant combination. It works by constricting blood vessels, reducing swelling in the nasal passages, and loosening mucus and lung secretions in the chest, making coughs more productive. The cough suppressant works in the brain to help decrease the cough reflex.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dextromethorphan/Guaifenesin/Pseudoephedrine Drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dextromethorphan/Guaifenesin/Pseudoephedrine Drops. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dextromethorphan/Guaifenesin/Pseudoephedrine Drops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dextromethorphan/Guaifenesin/Pseudoephedrine Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dextromethorphan/Guaifenesin/Pseudoephedrine Drops.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Dizziness; excitability; headache; nausea; nervousness or anxiety; trouble sleeping; weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dextromethorphan/Guaifenesin/Pseudoephedrine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.
Store Dextromethorphan/Guaifenesin/Pseudoephedrine Drops at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dextromethorphan/Guaifenesin/Pseudoephedrine Drops out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dextromethorphan/Guaifenesin/Pseudoephedrine Drops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Anlate may be available in the countries listed below.
Theophylline Sodium Glycinate is reported as an ingredient of Anlate in the following countries:
International Drug Name Search
Naftilux may be available in the countries listed below.
Naftidrofuryl oxalate (a derivative of Naftidrofuryl) is reported as an ingredient of Naftilux in the following countries:
International Drug Name Search
Ventolair Autohaler may be available in the countries listed below.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Ventolair Autohaler in the following countries:
International Drug Name Search
Hiperflex may be available in the countries listed below.
Chondroitin Polysulfate is reported as an ingredient of Hiperflex in the following countries:
Glucosamine sulfate (a derivative of Glucosamine) is reported as an ingredient of Hiperflex in the following countries:
International Drug Name Search
Glutoxim may be available in the countries listed below.
Glutathione sodium salt (a derivative of Glutathione) is reported as an ingredient of Glutoxim in the following countries:
International Drug Name Search
Enalapril Sumol may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril Sumol in the following countries:
International Drug Name Search
Hunperdal may be available in the countries listed below.
Risperidone is reported as an ingredient of Hunperdal in the following countries:
International Drug Name Search
Condilom may be available in the countries listed below.
Podophyllotoxin is reported as an ingredient of Condilom in the following countries:
International Drug Name Search
Heinix may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Heinix in the following countries:
International Drug Name Search
Crolin may be available in the countries listed below.
Citicoline sodium salt (a derivative of Citicoline) is reported as an ingredient of Crolin in the following countries:
International Drug Name Search
Anastrozol OrPha may be available in the countries listed below.
Anastrozole is reported as an ingredient of Anastrozol OrPha in the following countries:
International Drug Name Search
Hypan may be available in the countries listed below.
Nifedipine is reported as an ingredient of Hypan in the following countries:
International Drug Name Search
Lindaxa may be available in the countries listed below.
Sibutramine hydrochloride monohydrate (a derivative of Sibutramine) is reported as an ingredient of Lindaxa in the following countries:
International Drug Name Search
Hyderaparl may be available in the countries listed below.
Dihydroergotoxine mesilate (a derivative of Dihydroergotoxine) is reported as an ingredient of Hyderaparl in the following countries:
International Drug Name Search
Testosteron depo may be available in the countries listed below.
Testosterone 17ß-enantate (a derivative of Testosterone) is reported as an ingredient of Testosteron depo in the following countries:
International Drug Name Search
Hexal-Mpa may be available in the countries listed below.
Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Hexal-Mpa in the following countries:
International Drug Name Search
Midazolam Winthrop may be available in the countries listed below.
Midazolam is reported as an ingredient of Midazolam Winthrop in the following countries:
International Drug Name Search
Hyal-System may be available in the countries listed below.
Hyaluronic Acid is reported as an ingredient of Hyal-System in the following countries:
Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Hyal-System in the following countries:
International Drug Name Search
Humex toux sèche pholcodine may be available in the countries listed below.
Pholcodine is reported as an ingredient of Humex toux sèche pholcodine in the following countries:
International Drug Name Search
Tamsulosina Edigen may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosina Edigen in the following countries:
International Drug Name Search
Linipon may be available in the countries listed below.
Risperidone is reported as an ingredient of Linipon in the following countries:
International Drug Name Search
Hypace may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Hypace in the following countries:
Ramipril is reported as an ingredient of Hypace in the following countries:
International Drug Name Search
Berom may be available in the countries listed below.
Voglibose is reported as an ingredient of Berom in the following countries:
International Drug Name Search
Halkan may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Droperidol is reported as an ingredient of Halkan in the following countries:
International Drug Name Search
Fluconazol Farvet may be available in the countries listed below.
Fluconazole is reported as an ingredient of Fluconazol Farvet in the following countries:
International Drug Name Search
Fada Metronidazol may be available in the countries listed below.
Metronidazole is reported as an ingredient of Fada Metronidazol in the following countries:
International Drug Name Search
Candesartan Cilexetil may be available in the countries listed below.
Candesartan Cilexetil (BANM, USAN) is known as Candesartan in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| USAN | United States Adopted Name |
In some countries, this medicine may only be approved for veterinary use.
In the US, Selegiline (selegiline systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, monoamine oxidase inhibitors and is used to treat ADHD, Depression and Parkinson's Disease.
US matches:
Rec.INN
N04BD01
0014611-51-9
C13-H17-N
187
Treatment of Parkinson's disease
Inhibitor of monoamin oxidase type B (MAO-B)
Benzeneethanamine, N,α-dimethyl-N-2-propynyl-, (R)-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Labetalol HCL Actavis may be available in the countries listed below.
Labetalol hydrochloride (a derivative of Labetalol) is reported as an ingredient of Labetalol HCL Actavis in the following countries:
International Drug Name Search
Ipren may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ipren in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Hylartin in the following countries:
International Drug Name Search
Calcium Vitamine D3 EG may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of Calcium Vitamine D3 EG in the following countries:
Colecalciferol is reported as an ingredient of Calcium Vitamine D3 EG in the following countries:
International Drug Name Search
Dirolin may be available in the countries listed below.
Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Dirolin in the following countries:
International Drug Name Search
Farsix may be available in the countries listed below.
Furosemide is reported as an ingredient of Farsix in the following countries:
International Drug Name Search
Diclofenaco Normon may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenaco Normon in the following countries:
International Drug Name Search
Cefamandol Actavis may be available in the countries listed below.
Cefamandole is reported as an ingredient of Cefamandol Actavis in the following countries:
International Drug Name Search
Hémagène Tailleur may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Hémagène Tailleur in the following countries:
International Drug Name Search
Captopril AL may be available in the countries listed below.
Captopril is reported as an ingredient of Captopril AL in the following countries:
International Drug Name Search
Triostat is a brand name of liothyronine, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Triostat:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Triostat. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Triostat.
Octonativ-M may be available in the countries listed below.
Coagulation Factor VIII, Human is reported as an ingredient of Octonativ-M in the following countries:
International Drug Name Search
Hymecromon may be available in the countries listed below.
Hymecromone is reported as an ingredient of Hymecromon in the following countries:
International Drug Name Search
Gramoce A may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Gramoce A in the following countries:
Retinol is reported as an ingredient of Gramoce A in the following countries:
International Drug Name Search
Timonal may be available in the countries listed below.
Tiemonium Methylsulfate is reported as an ingredient of Timonal in the following countries:
International Drug Name Search
Antidepressants may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults. However, depression and certain other mental problems may also increase the risk of suicide. Talk with the patient's doctor to be sure that the benefits of using Oleptro Extended-Release Tablets outweigh the risks.
Family and caregivers must closely watch patients who take Oleptro Extended-Release Tablets. It is important to keep in close contact with the patient's doctor. Tell the doctor right away if the patient has symptoms like worsened depression, suicidal thoughts, or changes in behavior. Discuss any questions with the patient's doctor.
Treating depression. It may also be used for other conditions as determined by your doctor.
Oleptro Extended-Release Tablets are an antidepressant. It is thought to increase the activity of one of the brain chemicals (serotonin), which helps elevate mood.
Contact your doctor or health care provider right away if any of these apply to you.
Treatments for depression are getting better everyday and there are things you can start doing right away.
Some medical conditions may interact with Oleptro Extended-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Oleptro Extended-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Oleptro Extended-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Oleptro Extended-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Oleptro Extended-Release Tablets.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Blurred vision; constipation; decreased sexual desire or ability; dizziness; drowsiness; dry mouth; headache; lightheadedness when sitting up or standing; nausea; tiredness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry, or bloody stools; chest pain; decreased coordination; fainting; hallucinations; irregular heartbeat; new or worsening agitation, anxiety, panic attacks, aggressiveness, impulsiveness, irritability, hostility, exaggerated feeling of well-being, restlessness, trouble sleeping, or inability to sit still; prolonged, painful erection; seizures; severe or persistent dizziness; shortness of breath; suicidal thoughts or actions; swelling of the hands, ankles, or feet; symptoms of low blood sodium levels (eg, confusion, persistent headache, trouble concentrating, memory problems, weakness, unsteadiness, sluggishness, personality changes); tremor; unusual bruising or bleeding; vomit that looks like coffee grounds; worsening depression.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Oleptro side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include irregular heartbeat; prolonged, painful erection; seizures; severe drowsiness; slow or shallow breathing; vomiting.
Store Oleptro Extended-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C) in a tight, light-resistant container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oleptro Extended-Release Tablets out of the reach of children and away from pets.
This information is summary only. It does not contain all information about Oleptro Extended-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
dye-eth-il-PROE-pee-on hye-droe-KLOR-ide
In the U.S.
Available Dosage Forms:
Therapeutic Class: Appetite Suppressant, Centrally Acting
Chemical Class: Diethylpropion
Diethylpropion is used as part of a short-term plan, along with a low calorie diet, for weight reduction. It is used in obese patients who have not been able to lose weight with diet and exercise alone. Diethylpropion belongs to the group of medicines known as appetite suppressants.
diethylpropion is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For diethylpropion, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to diethylpropion or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of diethylpropion in children younger than 17 years of age. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of diethylpropion in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving diethylpropion.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | B | Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking diethylpropion, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using diethylpropion with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of diethylpropion. Make sure you tell your doctor if you have any other medical problems, especially:
Take diethylpropion only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. If too much is taken, it may become habit-forming (causing mental or physical dependence).
diethylpropion is available in two forms: the immediate-release tablets and the controlled-release tablets. Ask your doctor which dosage form is right for you.
Swallow the controlled-release tablets whole. Do not break, crush, or chew it.
Carefully follow your doctor's instructions for a reduced-calorie diet plan and regular exercise. Talk with your doctor before starting any exercise program.
The dose of diethylpropion will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of diethylpropion. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of diethylpropion, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your progress at regular visits to make sure that diethylpropion is working properly and does not cause any unwanted effects.
Do not use diethylpropion if you are also using similar medicines such as benzphetamine, mazindol, phendimetrazine, phentermine, Bontril®, Didrex®, or Suprenza™. Also, do not use diethylpropion if you have used an MAO inhibitor (MAOI) such as Eldepryl®, Marplan®, Nardil®, or Parnate® within the past 14 days. Using these medicines together may cause serious unwanted effects.
diethylpropion may be habit-forming. If you think diethylpropion is not working properly after you have taken it for 4 weeks, do not increase the dose. Instead, check with your doctor.
Stop using diethylpropion and check with your doctor right away if you notice a decrease in your ability to exercise, if you faint, or if you have chest pain, swelling of your feet or lower legs, or trouble with breathing. These may be symptoms of a very serious heart or lung problem.
diethylpropion may cause some people to become dizzy, lightheaded, or less alert than they are normally. Make sure you know how you react to diethylpropion before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.
diethylpropion will add to the effects of alcohol and other CNS depressants (medicines that make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; medicine for seizures (such as barbiturates); muscle relaxants; or anesthetics, including some dental anesthetics. Check with your medical doctor or dentist before taking any of the above while you are taking diethylpropion.
For diabetic patients: diethylpropion may affect blood sugar levels. If you notice a change in the results of your blood or urine sugar tests or if you have any questions, check with your doctor.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription and nonprescription (over-the-counter) medicines, dietary supplements, herbal remedies, or medicines for appetite control, asthma, colds, cough, hay fever, and sinus problems.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Get emergency help immediately if any of the following symptoms of overdose occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Ran-Ramipril may be available in the countries listed below.
Ramipril is reported as an ingredient of Ran-Ramipril in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of Stenorol in the following countries:
Bambermycin is reported as an ingredient of Stenorol in the following countries:
Halofuginone hydrobromide (a derivative of Halofuginone) is reported as an ingredient of Stenorol in the following countries:
Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Stenorol in the following countries:
Roxarsone is reported as an ingredient of Stenorol in the following countries:
Virginiamycin is reported as an ingredient of Stenorol in the following countries:
International Drug Name Search
Biurto Forte may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Biurto Forte in the following countries:
International Drug Name Search
Perlic may be available in the countries listed below.
Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Perlic in the following countries:
International Drug Name Search
Lacri-Vision may be available in the countries listed below.
Hypromellose is reported as an ingredient of Lacri-Vision in the following countries:
International Drug Name Search
Metronidazol Bottle-Pack may be available in the countries listed below.
Metronidazole is reported as an ingredient of Metronidazol Bottle-Pack in the following countries:
International Drug Name Search
HCG Fuji may be available in the countries listed below.
Chorionic Gonadotrophin is reported as an ingredient of HCG Fuji in the following countries:
International Drug Name Search
Evo-Conti may be available in the countries listed below.
Estradiol is reported as an ingredient of Evo-Conti in the following countries:
Norethisterone 17ß-acetate (a derivative of Norethisterone) is reported as an ingredient of Evo-Conti in the following countries:
International Drug Name Search
Zemalog may be available in the countries listed below.
Halcinonide is reported as an ingredient of Zemalog in the following countries:
International Drug Name Search
In the US, Platinol-AQ (cisplatin systemic) is a member of the drug class alkylating agents and is used to treat Bladder Cancer, Blood Cell Transplantation, Bone Marrow Transplantation, Brain Tumor, Cervical Cancer, Neuroblastoma, Non-Small Cell Lung Cancer, Osteogenic Sarcoma, Ovarian Cancer and Testicular Cancer.
US matches:
Cisplatin is reported as an ingredient of Platinol-AQ in the following countries:
International Drug Name Search
Lysiclox may be available in the countries listed below.
Cloxacillin sodium salt (a derivative of Cloxacillin) is reported as an ingredient of Lysiclox in the following countries:
International Drug Name Search
Taxegram may be available in the countries listed below.
Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Taxegram in the following countries:
International Drug Name Search
Veno SL may be available in the countries listed below.
Troxerutin is reported as an ingredient of Veno SL in the following countries:
International Drug Name Search
Oxprenolol Hydrochloride may be available in the countries listed below.
Oxprenolol Hydrochloride (BANM, JAN, USAN) is also known as Oxprenolol (Rec.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| JAN | Japanese Accepted Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
